In vitro activity of N-formimidoyl thienamycin (MK0787).
about
Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effectsIn vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureusThe pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.Biliary excretion of imipenem-cilastatin in hospitalized patients.Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections.Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteriaComparative activities of 13 beta-lactam antibioticsIn vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections.Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography.Multiple-dose pharmacokinetics of imipenem-cilastatin.Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidimeIn vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis.Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.In vitro activity of imipenem--a review.Effect of imipenem-cilastatin therapy on fecal flora.Degradation kinetics of imipenem in normal saline and in human serum.Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa.In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
P2860
Q28260317-C2747B1F-9E26-46EE-8DBE-FBB83F5F1D12Q30451373-6FF59109-3FE4-4E1E-AE3B-2400FA28893BQ34621525-A5ECEA55-C97F-48EB-951F-23FC4544A4F0Q35543208-13F01C1E-A5D9-4DB7-B127-A9756D175F78Q35573030-6CE8065C-CB0A-442E-9595-5E4F665E3FBDQ35640457-4AAFAC24-4E06-469E-A288-242DDD71453DQ35644246-F2FFA622-62DF-410E-BA4D-A3652A8DF031Q35648690-AED928C8-1F8E-47EA-A32E-9D6839D48B0EQ35673370-9D9A75C6-75BA-443F-B656-C5BF3671F8A4Q35676188-39BA27DC-D916-468D-95F6-674893DD2922Q35719143-208520D6-4495-4E84-9155-3380C19EB1A3Q35748622-0182407F-0AA4-4076-9F8D-5FB6C843E486Q37230830-B6E2CF60-DFB6-4D40-9224-E26A5583D365Q39848938-8C57909F-C5BE-43F3-BED5-6E65D1B1E4EFQ39849277-E36A9ABC-540F-41C5-A03B-E7751D3F6A4DQ39849463-26A6589C-B422-4465-8ABA-76AAE5D9837FQ39854704-C431909F-92BD-4459-8746-B9512769F5A8Q39855480-C737DFA7-20C3-4A10-8F92-E95ACFA5D29BQ39856621-EA5EC232-7BAC-4414-8563-65B5E75D2BE4Q39856722-BD02B56A-30C9-473E-AE18-8E34894B147DQ39856904-7220A640-F059-43A9-A002-91ACB869C86AQ39857331-E485FD2B-E733-4655-8586-8ABB823454B2Q40086604-ED72BC7C-97C7-4D87-ACB1-D84408E09330Q40192467-895D196F-D9C4-41DD-99BD-EFE983947D3CQ40283458-ADC125D6-F36C-424C-9E15-A18F008B16DBQ40283679-8055473D-D560-435C-97AC-53BF59E81870Q41912255-6FFB6159-F573-484F-9D6A-B2F6874EA518Q42175597-48DDAF25-5C00-46E2-840A-3505CE73ABAFQ42205383-FD87955B-03B7-4875-A621-5049EC8397D7Q42926907-712B9B39-0E29-4CD6-AFEE-CBEC23A32BB8Q42930469-A4A36E1C-0881-48D8-9C32-B83F21522A4F
P2860
In vitro activity of N-formimidoyl thienamycin (MK0787).
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
In vitro activity of N-formimidoyl thienamycin (MK0787).
@en
type
label
In vitro activity of N-formimidoyl thienamycin (MK0787).
@en
prefLabel
In vitro activity of N-formimidoyl thienamycin (MK0787).
@en
P2093
P2860
P356
P1476
In vitro activity of N-formimidoyl thienamycin (MK0787).
@en
P2093
P2860
P304
P356
10.1128/AAC.18.4.642
P407
P577
1980-10-01T00:00:00Z